Profound Medical Future Growth
Future criteria checks 2/6
Profound Medical is forecast to grow earnings and revenue by 47.5% and 44.2% per annum respectively while EPS is expected to grow by 53.7% per annum.
Key information
47.5%
Earnings growth rate
53.7%
EPS growth rate
| Medical Equipment earnings growth | 16.6% |
| Revenue growth rate | 44.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 10 May 2024 |
Recent future growth updates
Recent updates
Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?
May 03
Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?
Sep 15Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?
Sep 07Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation
Jan 07We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth
Jul 02We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned
May 13Analysts Expect Breakeven For Profound Medical Corp. (TSE:PRN) Before Long
May 07We Think Profound Medical (TSE:PRN) Can Afford To Drive Business Growth
Mar 25How Many Profound Medical Corp. (TSE:PRN) Shares Do Institutions Own?
Mar 04Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future
Jan 27
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 52 | -17 | -31 | -21 | 6 |
| 12/31/2025 | 30 | -23 | -31 | -30 | 6 |
| 12/31/2024 | 11 | -29 | -29 | -25 | 4 |
| 3/31/2024 | 7 | -28 | -22 | -22 | N/A |
| 12/31/2023 | 7 | -29 | -22 | -22 | N/A |
| 9/30/2023 | 6 | -29 | -22 | -22 | N/A |
| 6/30/2023 | 7 | -29 | -23 | -23 | N/A |
| 3/31/2023 | 7 | -27 | -24 | -24 | N/A |
| 12/31/2022 | 7 | -29 | -26 | -26 | N/A |
| 9/30/2022 | 6 | -29 | -24 | -24 | N/A |
| 6/30/2022 | 7 | -30 | -24 | -23 | N/A |
| 3/31/2022 | 8 | -31 | -24 | -24 | N/A |
| 12/31/2021 | 7 | -31 | -23 | -22 | N/A |
| 9/30/2021 | 9 | -28 | -26 | -25 | N/A |
| 6/30/2021 | 8 | -28 | -25 | -24 | N/A |
| 3/31/2021 | 7 | -26 | -20 | -20 | N/A |
| 12/31/2020 | 7 | -22 | -21 | -21 | N/A |
| 9/30/2020 | 7 | -18 | -19 | -19 | N/A |
| 6/30/2020 | 5 | -17 | -17 | -17 | N/A |
| 3/31/2020 | 4 | -16 | -20 | -20 | N/A |
| 12/31/2019 | 4 | -15 | -15 | -15 | N/A |
| 9/30/2019 | 3 | -15 | -13 | -13 | N/A |
| 6/30/2019 | 3 | -14 | -14 | -14 | N/A |
| 3/31/2019 | 3 | -14 | -13 | -13 | N/A |
| 12/31/2018 | 2 | -15 | -13 | -13 | N/A |
| 9/30/2018 | 2 | -16 | -14 | -14 | N/A |
| 6/30/2018 | 3 | -16 | -12 | -12 | N/A |
| 3/31/2018 | 4 | -15 | -12 | -11 | N/A |
| 12/31/2017 | 4 | -15 | N/A | -12 | N/A |
| 9/30/2017 | 2 | -15 | N/A | -12 | N/A |
| 6/30/2017 | 1 | -14 | N/A | -12 | N/A |
| 3/31/2017 | 0 | -12 | N/A | -11 | N/A |
| 12/31/2016 | N/A | -12 | N/A | -11 | N/A |
| 9/30/2016 | N/A | -11 | N/A | -9 | N/A |
| 6/30/2016 | N/A | -10 | N/A | -8 | N/A |
| 3/31/2016 | N/A | -14 | N/A | -7 | N/A |
| 12/31/2015 | N/A | -12 | N/A | -5 | N/A |
| 9/30/2015 | N/A | -12 | N/A | -5 | N/A |
| 6/30/2015 | N/A | -12 | N/A | -3 | N/A |
| 3/31/2015 | N/A | -8 | N/A | -2 | N/A |
| 12/31/2014 | N/A | -7 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PRN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PRN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PRN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PRN's revenue (44.2% per year) is forecast to grow faster than the Canadian market (7% per year).
High Growth Revenue: PRN's revenue (44.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PRN's Return on Equity is forecast to be high in 3 years time